| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,655,022 | 1,033,606 | 539,511 | 289,041 | 189,369 |
| Cost of Revenue
|
-1,096,901 | -475,613 | -274,427 | -145,890 | -76,957 |
|
Gross Profit
|
558,121 | 557,993 | 265,084 | 143,151 | 112,412 |
| Selling, General and Administrative Expenses
|
-531,751 | -633,372 | -379,645 | -303,264 | -197,236 |
|
Research and Development Expenses
|
-1,081,530 | -974,155 | -772,779 | -615,884 | -456,624 |
| Depreciation, Amortization and Depletion
|
-32,165 | -- | -30,278 | -27,015 | -17,523 |
| Other Income/Expense, Operating
|
103,570 | 70,973 | 39,073 | 15,441 | 14,196 |
|
Operating Income/Expenses
|
-1,509,711 | -1,536,554 | -1,113,351 | -930,722 | -657,187 |
|
Total Operating Profit/Loss
|
-951,590 | -978,561 | -848,267 | -787,571 | -544,775 |
| Total Net Finance Income/Expense
|
28,088 | 2,195 | -13,258 | -7,253 | -2,498 |
| Net Investment Income
|
761,164 | 930 | 844 | 695 | 15,175 |
| Irregular Income/Expenses
|
-23,576 | -14,037 | -31,855 | -22,198 | -19,025 |
|
Other Income/Expense, Non-Operating
|
-102,154 | -14,183 | 103 | -1,097 | -2,495 |
|
Non-Operating Income/Expenses, Total
|
663,522 | -25,095 | -44,166 | -29,853 | -8,843 |
|
Pretax Income
|
-288,068 | -1,003,656 | -892,433 | -817,424 | -553,618 |
|
Provision for Income Tax
|
0 | 0 | 0 | 0 | 0 |
|
Net Income from Continuing Operations
|
-288,068 | -1,003,656 | -892,433 | -817,424 | -553,618 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-288,068 | -1,003,656 | -892,433 | -817,424 | -553,618 |
|
Non-Controlling/Minority Interests
|
0 | -- | 0 | 26,117 | 29,779 |
|
Net Income after Non-Controlling/Minority Interests
|
-288,068 | -1,003,656 | -892,433 | -791,307 | -523,839 |
|
Net Income Available to Common Stockholders
|
-288,068 | -1,003,656 | -892,433 | -791,307 | -523,839 |
|
Diluted Net Income Available to Common Stockholders
|
-288,068 | -1,003,656 | -892,433 | -791,307 | -523,839 |
| Basic EPS
|
-0.37 | -1.32 | -1.17 | -1.04 | -0.69 |
| Diluted EPS
|
-0.37 | -1.32 | -1.17 | -1.04 | -0.69 |
|
Basic Weighted Average Shares Outstanding
|
743,827.694 | 762,953.208 | 762,953.208 | 762,953.208 | 762,953.208 |
|
Diluted Weighted Average Shares Outstanding
|
752,193.745 | 762,953.208 | 762,953.208 | 762,953.208 | 762,953.208 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-316,156 | -1,005,851 | -879,175 | -810,171 | -551,120 |
|
EBITDA
|
-122,027 | -832,631 | -724,202 | -691,904 | -460,760 |
|
Normalized EBITDA
|
-386,474 | -251,053 | -439,382 | -443,431 | -319,590 |
12/31/2022 - 1/8/2026
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade